Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA.

Caty CarreraNatalia CullellNuria P Torres-AguilaElena MuiñoAlejandro BustamanteAntonio DávalosElena López-CancioMarc RibóCarlos A MolinaEva Giralt-SteinhauerCarolina Soriano-TárragaMarina Mola-CaminalJordi Jiménez-CondeJaume RoquerCristófol Vives-BauzaRosa Díaz NavarroVictor ObachJuan Francisco ArenillasTomás SeguraGemma Serrano-HerasJoan Martí-FàbregasMarimar FreijoJuan Antonio CabezasTurgut TatlisumakLaura HeitschLaura IbañezCarlos CruchagaJin-Moo LeeDaniel StrbianJoan MontanerIsrael Fernández-Cadenasnull null

Published in: Neurology (2019)

The Genot-PA score predicts HT in patients with stroke treated with IV rtPA. Moreover, in an exploratory study, the score was associated with PH risk in mechanical thrombectomy-treated patients.

Keyphrases

newly diagnosed
end stage renal disease
chronic kidney disease
atrial fibrillation
peritoneal dialysis
subarachnoid hemorrhage